US 10265337
Use of A3 adenosine receptor agonist in osteoarthritis treatment
granted A61KA61K31/00A61K31/519
Quick answer
US patent 10265337 (Use of A3 adenosine receptor agonist in osteoarthritis treatment) held by CAN-FITE BIOPHARMA LTD. expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CAN-FITE BIOPHARMA LTD.
- Grant date
- Tue Apr 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/00, A61K31/519, A61K31/706, A61K31/7076